Citations

Clear

3042 citation(s) found for "Kumar, S".

A systematic review and meta‐analysis of new‐onset atrial fibrillation in the context of COVID‐19 infection
Rathore, Sawai Singh , Atulkar, Akanksha, Remala, Kavya, Corrales, Vanessa Vidaurre, Farrukh, Ameer Mustafa , Puar, Ravinderjeet Kaur, Yao, Sem Josue Nsanh, Ganipineni, Vijaya Durga Pradeep, Patel, Nirmal , Thota, Naganath, Deshmukh, Abhishek , Kumar, Ashish , Deshmukh, Abhishek J , Patel, Nirmal, Kumar, Ashish

Mayo Clinic

Journal of Cardiovascular Electrophysiology | January 8, 2024 | Volume: 35 | Issue: 3 | Pages: 478-487

10.1111/jce.16169 | PMID 38185923 Get It

AbstractNew‐onset atrial fibrillation (NOAF) in COVID‐19 raises significant clinical and public health issues. This systematic review and meta‐analysis aims to compile and analyze the current literature on NOAF in COVID‐19 and give a more comprehensive understanding of the prevalence and outcomes of NOAF in COVID‐19. A comprehensive literature search was carried out using several databases. The random effect model using inverse variance method and DerSimonian and Laird estimator of Tua2 was used to calculate the pooled prevalence and associated 95% confidence interval (CI). Results for outcome analysis were presented as odds ratios (ORs) with 95% CI and pooled using the Mantel‐Haenszel random‐effects model. The pooled prevalence of NOAF in COVID‐19 was 7.8% (95% CI: 6.54%–9.32%),a pooled estimate from 30 articles (81 929 COVID‐19 patients). Furthermore, our analysis reported that COVID‐19 patients with NOAF had a higher risk of developing severe disease compared with COVID‐19 patients without a history of atrial fibrillation (OR = 4.78, 95% CI: 3.75–6.09) and COVID‐19 patients with a history of pre‐existing atrial fibrillation (OR = 2.75, 95% CI: 2.10–3.59). Similarly, our analysis also indicated that COVID‐19 patients with NOAF had a higher risk of all‐cause mortality compared with, COVID‐19 patients without a history of atrial fibrillation (OR = 3.83, 95% CI: 2.99–4.92) and COVID‐19 patients with a history of pre‐existing atrial fibrillation (OR = 2.32, 95% CI: 1.35–3.96). The meta‐analysis did not reveal any significant publication bias. The results indicate a strong correlation between NOAF and a higher risk of severe illness and mortality. These results emphasize the importance of careful surveillance, early detection, and customized NOAF management strategies to improve clinical outcomes for COVID‐19 patients.
Fully Automated Agatston Score Calculation From Electrocardiography-Gated Cardiac Computed Tomography Using Deep Learning and Multi-Organ Segmentation: A Validation Study
Gautam, Ashish, Raghav, Prashant, Subramaniam, Vijay, Kumar, Sunil , Kumar, Sudeep , Singhal, Manphoul, Rathore, Samir, Iyengar, Srikanth, Rathore, Sudhir , Rathore, Sudhir , Subramaniam, Vijay, Jain, Dharmendra , Verma, Ashish Kumar , Singh, Parminder Pal , Gupta, Vikash

Mayo Clinic

Angiology | January 2, 2024 | Volume: 76 | Issue: 5 | Pages: 431-440

10.1177/00033197231225286 | PMID 38166442 Get It

To evaluate deep learning-based calcium segmentation and quantification on ECG-gated cardiac CT scans compared with manual evaluation. Automated calcium quantification was performed using a neural network based on mask regions with convolutional neural networks (R-CNNs) for multi-organ segmentation. Manual evaluation of calcium was carried out using proprietary software. This is a retrospective study of archived data. This study used 40 patients to train the segmentation model and 110 patients were used for the validation of the algorithm. The Pearson correlation coefficient between the reference actual and the computed predictive scores shows high level of correlation (0.84; P < .001) and high limits of agreement (±1.96 SD; −2000, 2000) in Bland–Altman plot analysis. The proposed method correctly classifies the risk group in 75.2% and classifies the subjects in the same group. In total, 81% of the predictive scores lie in the same categories and only seven patients out of 110 were more than one category off. For the presence/absence of coronary artery calcifications, the deep learning model achieved a sensitivity of 90% and a specificity of 94%. Fully automated model shows good correlation compared with reference standards. Automating process reduces evaluation time and optimizes clinical calcium scoring without additional resources.
FBSE-Based JPEG Image Compression
Chaudhary, Pradeep Kumar

Mayo Clinic

IEEE Sensors Letters | January 1, 2024 | Volume: 8 | Issue: 2 | Pages: 1-4

10.1109/lsens.2023.3349112 Get It

PF484 MARKERS ASSOCIATED WITH SHORT SURVIVAL IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA
Ruan, Gordon , Abeykoon, Jithma P. , Zanwar, Saurabh , Ansell, Stephen M. , Reeder, Craig B. , Lacy, Martha Q. , Kyle, Robert A. , Kumar, Shaji , Kapoor, Prashant , Gertz, Morie A. , Ailawadhi, Sikander , Dispenzieri, Angela , Dingli, David , Go, Ronald S. , Leung, Nelson , Buadi, Francis K. , Gonsalves, Wilson I. , Rajkumar, S. Vincent

Mayo Clinic

HemaSphere | December 31, 2023 | Volume: 3 | Issue: S1 | Pages: 194

10.1002/j.2572-9241.2019.tb00083.x Get It

Background:Waldenström Macroglobulinemia (WM) is a rare, indolent B‐cell lymphoplasmacytic malignancy. Patient outcomes are highly heterogeneous, with a proportion of patients surviving less than 5 years (short survivors) and another proportion that survive longer than 10 years. The laboratory parameters in the currently used International Prognostic Scoring System for WM (IPSSWM) include hemoglobin, serum IgM, platelet count, and serum β2‐microglobulin.Aims:We aim to identify unique patient characteristics and prognostic features associated with short survival in WM.Methods:The medical records of patients with active WM that were diagnosed at Mayo Clinic Rochester, Arizona, and Florida between January 1st, 1996 and December 31st, 2013 were reviewed. The patients with smoldering WM were excluded. Cohorts of patients who either survived ≤ 5 years (Short Survival Group) or those with an overall survival (OS) ≥ 10 years (Long Survival Group) from the diagnosis of active disease were compared. Survivors with a follow‐up of ≤ 5 years were not included in the analyses. Two‐sided Wilcoxon rank sum test and Chi square/Fisher's exact test were used to compare the continuous and categorical variables, respectively. The variables that were statistically significant on univariate analysis (P < 0.05) were included in a multivariate logisitic regression analysis.Results:Of 893 consecutively seen WM patients (median follow‐up of 9 years [95% CI 8.4–9.7]), we identified 387 patients who could be categorized into either the Short Survival Group (n = 171 patients, 44%) or the Long Survival Group (n = 216, 56%). The Short Survival Group had a median OS of 2.4 years (2.1–2.8) and median age at diagnosis of 73 years (42–93), while the Long Survival Group (n = 216, 56%) had a median OS of 18.9 years (16‐NR) and median age at diagnosis of 62 years (31–85). The baseline characteristics and significant findings between the two groups are listed in the Table. Parameters significant on univariate analysis included age >65 years, albumin < 3.5 g/dL, β2‐microglobulin >3 μg/ml, and LDH > upper limit of normal (ULN). On multivariate analysis, albumin <3.5 g/dL and LDH > ULN were independently associated with short survival. Among the Long Survivors, 60 (28%) patients survived 15 years or more.Summary/Conclusion:Lactate dehydrogenase above the ULN and serum albumin <3.5 g/dL are independent biomarkers of short survival in WM. The MYD88 L265P status and the size of serum IgM are not prognostic in WM. Our data suggest the need for simplification of the current staging system with the use of widely available markers: serum albumin and lactate dehydrogenase.image
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe
Rachamala, Hari K., Dutta, Shamit K., Wang, Enfeng , Angom, Ramcharan S, Nakka, Naga M, Kumar Dutta, Shamit, Madamsetty, Vijay Sagar , Angom, Ramcharan Singh , Nakka, Naga Malleswara Rao , Mukhopadhyay, Debabrata , Pal, Krishnendu

Mayo Clinic

No container title available | December 23, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3770403/v1 | PMID 38196607 Get It

Abstract Background Renal cell carcinoma (RCC) was historically considered to be less responsive to radiation therapy (RT) compared to other cancer indications. However, advancements in precision high-dose radiation delivery through single-fraction and multi-fraction stereotactic ablative radiotherapy (SABR) have led to better outcomes and reduced treatment-related toxicities, sparking renewed interest in using RT to treat RCC. Moreover, numerous studies have revealed that certain therapeutic agents including chemotherapies can increase the sensitivity of tumors to RT, leading to a growing interest in combining these treatments. Here, we developed a rational combination of two radiosensitizers in a tumor-targeted liposomal formulation for augmenting RT in RCC. The objective of this study is to assess the efficacy of a tumor-targeted liposomal formulation combining the mTOR inhibitor everolimus (E) with the survivin inhibitor YM155 (Y) in enhancing the sensitivity of RCC tumors to radiation. Experimental Design: We slightly modified our previously published tumor-targeted liposomal formulation to develop a rational combination of E and Y in a single liposomal formulation (EY-L) and assessed its efficacy in RCC cell lines in vitro and in RCC tumors in vivo. We further investigated how well EY-L sensitizes RCC cell lines and tumors toward radiation and explored the underlying mechanism of radiosensitization. Results EY-L outperformed the corresponding single drug-loaded formulations E-L and Y-L in terms of containing primary tumor growth and improving survival in an immunocompetent syngeneic mouse model of RCC. EY-L also exhibited significantly higher sensitization of RCC cells towards radiation in vitro than E-L and Y-L. Additionally, EY-L sensitized RCC tumors towards radiation therapy in xenograft and murine RCC models. EY-L mediated induction of mitotic catastrophe via downregulation of multiple cell cycle checkpoints and DNA damage repair pathways could be responsible for the augmentation of radiation therapy. Conclusion Taken together, our study demonstrated the efficacy of a strategic combination therapy in sensitizing RCC to radiation therapy via inhibition of DNA damage repair and a substantial increase in mitotic catastrophe. This combination therapy may find its use in the augmentation of radiation therapy during the treatment of RCC patients.
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma
Anker, Christopher J. , Abood, Gerard, Hallemeier, Christopher L. , Kennedy, Timothy J., Kumar, Rachit , Lee, Percy , Sharma, Navesh , Williams, Vonetta M. , Russo, Suzanne , Jethwa, Krishan R. , Kim, Ed, Berlin, Jordan D. , Tchelebi, Leila T. , Hallemeier, Christopher Leigh , Jabbour, Salma K , Small, William , Russo, Suzanne

Mayo Clinic

American Journal of Clinical Oncology | December 22, 2023 | Volume: 47 | Issue: 4 | Pages: 185-199

10.1097/coc.0000000000001076 | PMID 38131628 Get It

For patients with locoregionally confined pancreatic ductal adenocarcinoma (PDAC), margin-negative surgical resection is the only known curative treatment; however, the majority of patients are not operable candidates at initial diagnosis. Among patients with resectable disease who undergo surgery alone, the 5-year survival remains poor. Adjuvant therapies, including systemic therapy or chemoradiation, are utilized as they improve locoregional control and overall survival. There has been increasing interest in the use of neoadjuvant therapy to obtain early control of occult metastatic disease, allow local tumor response to facilitate margin-negative resection, and provide a test of time and biology to assist with the selection of candidates most likely to benefit from radical surgical resection. However, limited guidance exists regarding the relative effectiveness of treatment options. In this systematic review, the American Radium Society multidisciplinary gastrointestinal expert panel convened to develop Appropriate Use Criteria evaluating the evidence regarding neoadjuvant treatment for patients with PDAC, including surgery, systemic therapy, and radiotherapy, in terms of oncologic outcomes and quality of life. The evidence was assessed using the Population, Intervention, Comparator, Outcome, and Study (PICOS) design framework and “Preferred Reporting Items for Systematic Reviews and Meta-analyses” 2020 methodology. Eligible studies included phases 2 to 3 trials, meta-analyses, and retrospective analyses published between January 1, 2012 and December 30, 2022 in the Ovid Medline database. A summary of recommendations based on the available literature is outlined to guide practitioners in the management of patients with PDAC.
The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI–Dynamic Contrast‐Enhanced challenge
Shalom, Eve , Kim, Harrison , Heijden, Rianne A. van der , Ahmed, Zaki , Patel, Reyna, DiCarlo, Julie C. , Yankeelov, Thomas E. , Stokes, Ashley M. , Grech‐Sollars, Matthew , Sahoo, Prativa , Verma, Sanjay Kumar , Rathore, Divya, Kazerouni, Anum S. , LoCastro, Eve , Paudyal, Ramesh , Wolansky, Ivan A. , Shukla‐Dave, Amita , Schouten, Pepijn, Gurney‐Champion, Oliver J. , Macíček, Ondřej , Vitouš, Jiří , Das, Ayesha , Mikheev, Artem , Rusinek, Henry , Cristinacce, Penny L. Hubbard , Little, Ross A. , Cheung, Susan , O’Connor, James P.B. , Moloney, Brendan, Bobholz, Samuel , Duenweg, Savannah , Laue, Hendrik , Sung, Kyunghyun , Nabavizadeh, Ali , Rad, Hamidreza Saligheh , Hu, Leland , Kazerooni, Anahita Fathi , Shalom, Eve S , van der Heijden, Rianne A , Hormuth, David A , DiCarlo, Julie C , Yankeelov, Thomas E , Dortch, Richard D , Grech-Sollars, Matthew , Kazerouni, Anum S , Partridge, Savannah C , LoCastro, Eve , Wolansky, Ivan A , Jiřík, Radovan , Macíček, Ondřej , Bartoš, Michal , Vitouš, Jiří , Das, Ayesha Bharadwaj , Kim, S Gene , Rusinek, Henry , Berks, Michael , Hubbard Cristinacce, Penny L , O'Connor, James P B , Parker, Geoff J M , LaViolette, Peter S , Bobholz, Samuel , Duenweg, Savannah , Virostko, John , Sung, Kyunghyun , Saligheh Rad, Hamidreza , Sourbron, Steven , Bell, Laura C , Fathi Kazerooni, Anahita , Paudyal, Ramesh , Shukla-Dave, Amita , Sisco, Nicholas J. , Inglese, Marianna , Toschi, Nicola , Singh, Anup K. , Schouten, Pepijn, Bokacheva, Louisa , Bell, Laura C.

Mayo Clinic

Magnetic Resonance in Medicine | December 20, 2023 | Volume: 91 | Issue: 5 | Pages: 1803-1821

10.1002/mrm.29909 | PMID 38115695 Get It

AbstractPurpose has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging–Dynamic Contrast‐Enhanced (OSIPI‐DCE) challenge was designed to benchmark methods to better help the efforts to standardize measurement.MethodsA framework was created to evaluate values produced by DCE‐MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants' values, the applied software, and a standard operating procedure. These were evaluated using the proposed score defined with accuracy, repeatability, and reproducibility components.ResultsAcross the 10 received submissions, the score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0–1 = lowest–highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.ConclusionsThis study reports results from the OSIPI‐DCE challenge and highlights the high inter‐software variability within estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real‐world clinical setting, many of these tools may perform differently with different benchmarking methodology.
Abstract 18555: Global Burden of Congenital Heart Disease and Its Trend From 1990-2019 in 38 OECD Countries: A Benchmarking Analysis for the Global Burden of Disease Study
Patel, Hardik Y, Ratheesh, Rani, anum, anum, Thota, Anjani Kumar, Rachapudi, Shasank, John, Jobby , Koppana, Viswaja, Hassan, Khawaja Muthammir , Anum, ., Desai, Hardik Dineshbhai

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.18555 Get It

Introduction: Congenital heart disease (CHD) is the 1st leading cause of deaths among all deaths associated with congenital birth defects in (Organization for Economic Cooperation and Development) OECD countries, constituting a significant health concern that imposes a substantial burden on healthcare systems and society. Methods: Using the Global Burden of Disease methodology, this study assesses the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) associated with CHD in 38 OECD countries by sex, year, and location, covering the period from 1990 to 2019. The results are presented in both all age counts and age standardized rates (ASR) per 100,000 person-years. Results: From 1990 to 2019, the total number of prevalent cases of CHD increased from 1,469,128 (95%UI: 1,292,909-1,671,743) to 1,590,654 (1,387,114-1,815,338). In contrast, CHD-related deaths decreased from 37,291 (31,629-47,869) in 1990 to 13,886 (10,668-16,919) in 2019. The annual percentage of change (APC) in age-standardized mortality (ASMR) decreased by 60%, while the ASIR showed almost no change but decreased by 3%. Notably, the highest APC in ASIR was observed in Czechia (27%), Sweden (21%), Hungary (18%), and the United States (11%), while Turkey (28%) and Canada (21%) had the lowest APC increases. The highest APC increase in ASIR among females was observed in France (29%) Conclusions: Despite a decrease in the burden of CHD over the last three decades, it remains a significant concern in OECD countries. The impact of CHD is felt by individuals, families, healthcare systems, and the economy, emphasizing the ongoing need for comprehensive strategies to address this burden.
Abstract 17804: Prediabetes and Stroke Risk in Hospitalized Non-Diabetic Geriatric Patients With Atrial Fibrillation: Unfurling the Association Through Population-Based Analysis
Sampath, Shrikanth , Srivastava, Archit , Suchday, Pooja , Bhanushali, Aditi K, Behera, Alkananda , MEHTA, KAMYA, Eppalapally, Akhil kumar, Bollampalli, Ram Prasanjith Reddy, Desai, Rupak

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.17804 Get It

Background: The association of prediabetes (pDM) with stroke risk in non-diabetic geriatric patients with AF is unclear. The findings from this analysis contribute to a better understanding of the interrelation between pDM, AF, and stroke, highlighting the need for targeted interventions and risk management strategies in this vulnerable population. Methods: Utilizing the 2019 National Inpatient Sample and employing ICD-10 CM coding, we identified all non-diabetic geriatric admissions with AF. Patients were categorized into two groups: pDM+ and pDM-. The primary outcomes of interest were stroke incidence, odds and potential sex disparities in odds as a risk factor for stroke in geriatric patients with AF. Results: Of the total 218130 non-diabetic geriatric AF admissions, 3525(1.6%) had pDM. The pDM+ cohort was relatively younger (median 75 vs 77 years), and often consisted of females (57.9%; p<0.359), white (80.1%), and from the higher-income quartile (28.5%); (p<0.001). The preDM+ group had significantly higher rates of complicated HTN (50.2 vs 43.6%), hyperlipidemia (66.4 vs 53.7%), obesity (30.2 vs 13.6%), PVD (15.3 vs 9.9%), stroke (1.4 vs 0.8%). After adjusting for baseline characteristics/comorbidities, the pDM+ cohort with AF admissions showed a higher rate and significantly higher odds of stroke vs the pDM- cohort (1.4% vs. 0.8%, OR 2.00, 95%CI 1.06-3.77; p=0.033). On subgroup analyses, males had a stronger association (OR 5.48, 95%CI 1.43-21.02; p=0.013) vs. females. Conclusion: Our research revealed that geriatric patients hospitalized with AF who had concomitant pDM were twice likely to develop stroke, with male preponderance. Further research is warranted to develop tailored interventions to mitigate the risk of stroke in AF patients with pDM.
Abstract 17795: Increased Long-Term Odds of Atrial Fibrillation in Overweight or Obese Young Men: A Systematic Review and Meta-Analysis
Doshi, Preet, Ancira, Santiago Saenz , Patel, Yash, Ornelas, Javier Higuera, Geddada, Sunitha, Chiluveru, Sricharan, kumar, Sandhya Shanthosh, Tera, Chenna Reddy, Chalasani, Vardhan, Patta, Harika Varma Chintalapalli, Vyas, Ankit , Bansal, Prerna B. , Desai, Rupak

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.17795 Get It

Aim: Studies in the past have linked obesity as a risk factor for atrial fibrillation (AF). However, there is a paucity of data on this influence in young adult males. This meta-analysis aims to evaluate and stratify the association between BMI and AF among young men. Methods: PubMed, Scopus, and Google Scholar databases were systematically reviewed for studies reporting long term-incidence of atrial fibrillation in young male adults (18-49 years) with obesity (BMI>30 kg/m 2 ), and overweight BMI (BMI 20-25 kg/m 2 ). Random effects models were used for the meta-analyses and subgroup analyses. I 2 statistics were used to identify (>50%) heterogeneity. A sensitivity analysis was performed using leave-one-out method. Results: Six studies with a total of 21,856,538 individuals were screened, out of which 6,732,531 young males with higher BMI and obesity were evaluated for the risk of Atrial fibrillation for a median follow-up duration of 6.3 years (3.3 - 29 years range). South Korean and Japanese studies together constituted 99.86% of the study population. Most commonly associated comorbidities were hypertension, diabetes mellitus type 2, dyslipidemia and smoking. The unadjusted HR showed a significant association between overweight (BMI 25-30) [OR:1.42, (95%CI:1.28-1.58, I 2 : 75.86%; p< 0.01] and obesity (BMI >30) and AF [OR: 2.02, (95%CI: 1.77-2.29, I 2 :64.3%; p=0.02] in young adult males. After multivariable analysis, the association remained significant for overweight [OR:1.22, 95%CI: 1.14-1.32, I 2 : 82.74%; p< 0.01] and obesity [OR:1.48, 95%CI: 1.29-1.71, I 2 : 90.43%; p< 0.01]. Sensitivity analysis indicated that no single study unduly influenced the pooled estimates. Conclusion: This meta-analysis revealed that higher BMI (overweight and obese) in young males is associated with an increased long-term risk of AF over a median follow-up duration of 6.3 years.